AVBP
ArriVent BioPharma, Inc.
16.70$
+0.1%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 4.58 | 4.58 | 0.30 | 0.26 | 0.31 | 0.61 | 0.43 | 0.60 | 0.51 | 0.65 | 0.60 | 0.60 | 1.81 | 0.79 | 0.77 | 0.84 | 0.83 | 0.89 | 3.03 | |
| 1.17 | 1.17 | 0.05 | 0.05 | 0.06 | 0.07 | 0.07 | 0.09 | 0.11 | 0.12 | 0.12 | 0.11 | 0.16 | 0.17 | 0.15 | 0.17 | 0.19 | 0.22 | 0.66 | |
| 5.76 | 5.76 | 0.35 | 0.31 | 0.36 | 0.67 | 0.50 | 0.69 | 0.62 | 0.77 | 0.72 | 0.71 | 1.97 | 0.96 | 0.91 | 1.01 | 1.02 | 1.11 | 3.70 | |
| -5.76 | -5.76 | -0.35 | -0.31 | -0.36 | -0.67 | -0.50 | -0.69 | -0.62 | -0.77 | -0.72 | -0.71 | -1.97 | -0.96 | -0.91 | -1.01 | -1.02 | -1.11 | -3.70 | |
| -5.76 | -5.76 | -0.35 | -0.31 | -0.36 | -0.64 | -0.43 | -0.63 | -0.52 | -0.65 | -0.61 | -0.61 | -1.90 | -0.90 | -0.83 | -0.92 | -0.96 | -1.05 | -3.44 | |
| – | – | -0.35 | -0.31 | -0.36 | – | -0.50 | -0.69 | – | – | – | – | – | – | – | – | – | – | – | |
| -5.76 | -5.76 | -0.35 | -0.31 | -0.36 | -0.64 | -0.43 | -0.63 | -0.52 | -0.65 | -0.61 | -0.61 | -1.90 | -0.90 | -0.83 | -0.92 | -0.96 | -1.05 | -3.44 | |
| – | – | -0.35 | -0.31 | -0.36 | -0.64 | -0.43 | -0.63 | -0.52 | -0.65 | -0.61 | -0.61 | -1.90 | -0.90 | -0.83 | -0.92 | -0.96 | -1.05 | -3.44 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.